View in EDS HTML Full Text PDF Full Text

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.

Saved in:
Bibliographic Details
Title: Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.
Authors: Xie H; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Xiang M; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Zhang M; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Meng F; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Qi Y; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China., Chen K; Department of Nephrology, Daping Hospital, Army Medical University, Chongqing, China., Zeng D; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.
Source: Frontiers in immunology [Front Immunol] 2026 Jun 23; Vol. 17, pp. 1722204. Date of Electronic Publication: 2026 Jun 23 (Print Publication: 2026).
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42416063
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Xie+H%22">Xie H</searchLink>; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Xiang+M%22">Xiang M</searchLink>; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Meng+F%22">Meng F</searchLink>; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Qi+Y%22">Qi Y</searchLink>; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Department of Nephrology, Daping Hospital, Army Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Zeng+D%22">Zeng D</searchLink>; Department of Hematology, Daping Hospital, Army Medical University, Chongqing, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Jun 23; Vol. 17, pp. 1722204. <i>Date of Electronic Publication: </i>2026 Jun 23 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42416063
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1722204
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1722204
    Titles:
      – TitleFull: Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Xie H
      – PersonEntity:
          Name:
            NameFull: Xiang M
      – PersonEntity:
          Name:
            NameFull: Zhang M
      – PersonEntity:
          Name:
            NameFull: Meng F
      – PersonEntity:
          Name:
            NameFull: Qi Y
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Zeng D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 06
              Text: 2026 Jun 23
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1